FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral
Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The
Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The
The challenge is determining whether wearable data is reliable enough to relieve the review burden, guide care, support reimbursement, or reassure a patient who is
Healthcare interoperability isn’t an abstract concept; it’s about human connection, building trust and easing burden on patients and their care providers. The post Trust, Technology
At the annual Medicarians conference in Las Vegas that draws brokers, agents, agency owners and field marketing organizations, among others, Dawn Maroney suggested that payers
Oscar Health launched Lucie, a marketplace aimed at making healthcare more shoppable. The post Oscar Health Seeks to Build ‘Airbnb for Healthcare’ with New Marketplace,
Tortugas Neurosciences’ two lead programs are in-licensed oral small molecules in development for schizophrenia and tinnitus. The startup is led by veterans of Sage Therapeutics,
HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.